Moberg Pharma AB (Formerly known as Moberg Derma) Secures Financing to Facilitate Portfolio Expansion  
7/2/2013 8:08:19 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Stockholm, July 2, 2013. Based on the authorization from the 2013 Annual General Meeting, the Board of Moberg Pharma AB (OMX: MOB)(“Moberg Pharma”, the “Company” or the “Group”) has resolved to issue new shares with deviation from the shareholders’ preferential rights to Bure Equity AB (publ) (“Bure”). The purpose of the financing is to facilitate forthcoming additions to the Company´s product portfolio.

Help employers find you! Check out all the jobs and post your resume.